Skip to main content
Log in

Genetic testing plus donepezil cost effective for AMCI?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Djalalov S, et al. Genetic Testing in Combination with Preventive Donepezil Treatment for Patients with Amnestic Mild Cognitive Impairment : An Exploratory Economic Evaluation of Personalized Medicine.Molecular Diagnosis and Therapy : 28 Nov 2012. Available from: URL: http://dx.doi.org/10.1007/s40291-012-0010-7

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Genetic testing plus donepezil cost effective for AMCI?. PharmacoEconomics & Outcomes News 669, 6 (2013). https://doi.org/10.1007/s40274-013-0052-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0052-z

Navigation